CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox®) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Treatment of Relapsed or Refractory Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04791228
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:00.570159+00:00
Published At: 2025-01-01T00:00:00+00:00
Record Updated At: 2025-01-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumors", "Soft Tissue Sarcoma", "Ewing Sarcoma", "Malignant Epithelial Neoplasm", "Rhabdomyosarcoma", "Wilms Tumor", "Hepatic Tumor", "Germ Cell Tumor", "Bone Metastases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-01"
protocolSection.identificationModule.nctId: "NCT04791228"
protocolSection.identificationModule.officialTitle: "A Pilot Study of Lyso-thermosensitive Liposomal Doxorubicin (LTLD, ThermoDox\u00ae) and Magnetic Resonance-Guided High Intensity Focused Ultrasound (MR-HIFU) for Treatment of Relapsed or Refractory Solid Tumors"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.